Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Mol Genet Metab. 2010 Jun 22;101(2-3):134–140. doi: 10.1016/j.ymgme.2010.06.005

Figure 2. Percentiles of three canonical pathways over four IPA releases (v6.0, v6.5, v7.0, v7.1).

Figure 2

A canonical pathway analysis of 678 probesets of interest was conducted with four different IPA releases. “Glucocorticoid Receptor Signaling” experienced the most substantial change between consecutive releases, decreasing from the 79th percentile (v6.0) to the 31st percentile (v6.5). “PPAR/RXR Activation” experienced the most substantial percentile change between v6.0 and v7.1, decreasing from 48th to 4th. Percentiles were calculated out of the set of pathways that achieved significance at the 0.05 level for each analysis, where v6.0 had 29 significant pathways, v6.5 had 39, v7.0 had 48, v7.1 had 53.